View all news

Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa

08/31/2021

Multimedia Files:

View all news
Questions? Please contact us:
1-800-950-5089 investor-relations@its.jnj.com